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Learning and memory disorders arise from distinct age-associated processes, and aging animals are often used as a model of
memory impairment. The root of Polygala tenuifolia has been commonly used in some Asian countries as memory enhancer and
its memory improvement has been reported in various animal models. However, there is less research to verify its effect onmemory
functions in aged animals. Herein, the memory-enhancing effects of the crude extract of Polygala tenuifolia (EPT) on normal aged
mice were assessed by Morris water maze (MWM) and step-down passive avoidance tests. In MWM tests, the impaired spatial
memory of the agedmice was partly reversed by EPT (100 and 200mg/kg; P < 0.05) as comparedwith the aged controlmice. In step-
down tests, the nonspatial memory of the aged mice was improved by EPT (100 and 200mg/kg; P < 0.05). Additionally, EPT could
increase superoxide dismutase (SOD) and catalase (CAT) activities, inhibit monoamine oxidase (MAO) and acetyl cholinesterase
(AChE) activities, and decrease the levels of malondialdehyde (MDA) in the brain tissue of the aged mice. The results showed that
EPT improved memory functions of the aged mice probably via its antioxidant properties and via decreasing the activities of MAO
and AChE.
1. Introduction
As a result of increased human life expectancy, age-related
learning andmemory disorders have become prevalent in the
aging population, even in the absence of neurodegenerative
diseases such as Alzheimer’s and Parkinson’s disease. To
tackle such a major global healthcare issue, it is vital to
develop effective prophylactic and therapeutic agents for
enhancing and maintaining memory functions before the
onset of memory impairments [1–3].
Traditional ChineseMedicine (TCM)has been frequently
used for treatingmemory and cognitive deficits for thousands
of years. The root of Polygala tenuifolia, a well-known
medicinal plant in TCM, named as “Yuan Zhi,” has been
commonly used as memory enhancer in China, and it is also
included in some traditional prescriptions treating central
nervous system disturbances, such as amnesia and dementia
[4]. Recently, a number of studies have revealed that the root
of Polygala tenuifolia could improve learning and memory
function in animal models induced by scopolamine [5],
KCN [6], 𝛽-amyloid peptide [7], stress, hypoxia [8], and
accelerated senescence [9]. However, there is less research to
verify thememory-enhancing effects of Polygala tenuifolia on
the normal aged animals.
In the present study, we aim to investigate the effects of
the crude extract of Polygala tenuifolia (EPT) on learning
andmemory impairments of the normal agedmice. Learning
and memory parameters are evaluated by using Morris water
maze and step-down passive avoidance tests. Additionally,
potential mechanisms are also examined. Our results provide
evidence that the improvement of learning and memory
functions in normal aged mice by EPT may be via antago-
nizing oxidative damages as well as decreasing the activities
of MAO and AChE.
2. Materials and Methods
2.1. Preparation of EPT. Air-dried roots of Polygala tenuifolia
Willd. were purchased from theCompany of ChineseMateria
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Figure 1: Experimental procedure.
Medica in Beijing and identified by Professor Bengang
Zhang from the Institute of Medicinal Plant Development,
Chinese Academy of Medical Sciences (Beijing, China).
A voucher specimen (no. 20090815) has been deposited
in the Herbarium of the Institute. The dried roots (2 kg)
were cut into small pieces and extracted exhaustively with
boiling water for three times, each time for 1 h. The filtered
liquid was loaded to a column of macroporous resin D101
(6 kg) (Cang Bon Adsorber Technology Co., Ltd., China)
and eluted successively with water and ethanol-water (9 : 1,
v/v), respectively. The ethanol-water liquid was evaporated
in vacuo to yield a pale yellow residue (105 g), which is
designated the crude extract of Polygala tenuifolia (EPT).
2.2. Drugs and Reagents. The test kits of malondialde-
hyde (MDA), superoxide dismutase (SOD), catalase (CAT),
monoamine oxidase (MAO), and acetyl cholinesterase
(AChE) were all purchased from Nanjing Jiancheng Bioengi-
neering Institute (Nanjing, China). All the other reagents
were of analytical grade from Sigma.
2.3. Animals. Female C57BL/6J mice (Sixty 15-month-old
mice and twelve 3-month-oldmice) were purchased from the
Laboratory Animal Institute of Chinese Academy of Medical
Science (Certification no. SCXK 2004-0006, Beijing, China).
They were housed in groups of five animals per cage under a
12 : 12 h light-dark cycle at constant temperature (23∘C ± 2∘C)
and humidity (50% ± 10%). The animals had free access to
standard chow diet and sterilized drinking water in the SPF
animal house. The 3-month-old mice were used as the nor-
mal control group. The 15-month-old mice were randomly
assigned into six groups, including the normal control group,
the aged control group, galantamine (3mg/kg) group, and the
various concentrations of EPT (50, 100, and 200mg/kg, resp.)
groups. The drug administration and behavioral assays were
performed using a double-blind method. All animal exper-
iments were conducted in compliance with the “Guide for
the Care and Use of Laboratory Animals” of the Institute of
Medicinal Plant Development, Chinese Academy of Medical
Science and Peking Union Medical College.
2.4. Experimental Procedures. After 2 days of habituation,
mice received orally water (the normal control group and
the aged control group), galantamine (3mg/kg), or various
concentrations of EPT (50, 100, and 200mg/kg) for a period
of 4 weeks before behavioral measurement was assessed.
Locomotive activities of mice were tested in open-field on
the first day of behavioral test. Morris water maze tests were
carried out on day 2 to day 8 and day 23 to day 25; step-down
passive avoidance tests were valued on day 15 to day 16 and
day 28, respectively.Then, the mice were decapitated, and the
brain tissues were dissected quickly on ice for detection of the
content of MDA and the activities of SOD, CAT, MAO, and
AChE. The procedure was presented in Figure 1.
2.5. Open-Field Test. The effect of EPT on mice locomotor
activities was evaluated automatically using an open-field
computer-aided controlling system as described in the lit-
eratures [10, 11]. The apparatus consists of four metal tanks
(30 cm in diameter and 40 cm in height) with a video camera
fixed at the top, and the apparatus was illuminated by a light
source of 120 Lux on the ceiling. Experimentswere performed
in a quiet room; four mice were tested simultaneously.Thirty
minutes after drug administration, each mouse was placed at
the center of the metal tank and allowed to explore freely for
5min. Then, the distance traveled by mouse was measured
for 10min, which was recorded to evaluate the locomotive
activity of the mouse.
2.6. Morris Water Maze Test
2.6.1. Apparatus. The apparatus (developed by Institute of
Medicinal Plant Development, Chinese Academy of Medical
Sciences, and Chinese Astronaut Center, Beijing, China)
is a circular water pool (100 cm in diameter and 40 cm
in height) with constant clues external to the maze for
spatial orientation of the mice. The water was made opaque
by adding black ink to prevent animals from seeing the
submerged platform. The water temperature was kept at 24–
26∘C during the whole experiment. An invisible platform
(6 cm in diameter and 15 cm in height) providing the only
escape from water was placed 1.5 cm below the water surface.
The pool was divided into four quadrants by a computerized
tracking and image analyzer system. Two principal axes of
the maze intersect perpendicularly to one another to create
an imaginary “+.”The end of each line demarcates one of the
four cardinal points: north (N), south (S), west (W), and east
(E).
2.6.2. Test Procedure. On days 2 to 8 of behavioral mea-
surement, Morris water maze was used to assess the spatial
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reference memory consisting of an acquisition phase and a
probe trial. Memory retention of the mice was tested on days
23 to 25.
In the acquisition phase, mice were placed in the pool
containing platform to adapt to the environment before
training. Then mice were subjected to two trials each day for
6 days to find the submerged platform that was located in the
center of the SE quadrant of the pool and remained at the
same position throughout the whole experiment. Two-day
training of four trials contributed to a session. For each trial,
the mouse was placed for 15 sec on the platform for learning;
then, it was gently released into the pool facing the wall. Four
different release points (NE, SE, SW, and NW) were varied
randomly for each session. Animals were given a maximum
of 60 sec to find the platform. If the mouse failed to find the
platform within 60 sec, it was gently guided to the platform
and stayed there for 10 sec, and its escape latencywas recorded
as 60 sec. If an animal found the platform within 60 sec, it
was allowed to remain there for 10 sec and was then placed
into a cage until next trial. After completion of daily training,
the animals were returned to their cages for rest. Escape
rate, escape latency, and swimming speed were collected to
evaluate the ability of learning andmemory function of mice.
On the 8th day of behavioral measurement, the spatial
probe trials were tested.The platform was removed, and each
mouse was placed into the water on the opposite side of the
SE quadrant. They were allowed to swim freely for 120 s. The
crossing numbers over the position at which the platformhad
been located, the swimming time, and the swimming distance
spent in the target quadrant were recorded as measures for
spatial memory.
Two weeks after Morris water maze tests, memory reten-
tion tests were given. Neither the platform nor the starting
point was fixed; mice were released in the opposite quadrant.
This training had been performed 2 times each day for 3
days. The average of two trials during a day was determined
as escape latency for the purpose of evaluating memory
retention abilities of mice.
2.7. Step-Down Test. Step-down passive avoidance tests were
carried out in a chamber to evaluate the effects of EPT on
learning and memory function of the aged mice. The floor
of the chamber consisted of copper rods and a well-insulated
platform made of rubber in one corner of the chamber. The
animals were placed in the chamber for 3min adaptation at
the beginning of training. After adaptation, mice were placed
on the floor and received an immediate mild electrical shock
for 5 minutes (25V). To avoid the shock, mice displayed
an instinctive reaction to jump back onto the platform. The
latency to step down on the grid with all four paws was
measured. The time on the safe zone (on the platform) and
time on the error zone (on the grid) were recorded within
4min. The tests consisted of three phases of acquisition,
consolidation, and retrieval, which were carried out on day
15, day 16, and day 28, respectively.
2.8. Preparation of Brain Tissue Samples and Biochemical
Evaluation. After behavioral measurements, all the mice
were sacrificed by decapitation; the brain tissues were quickly
removed, washed with cold saline solution, followed by
50mM Tris-HCl buffer (pH 7.4), and weighed. Then, it was
placed into a glass bottle, labeled, and stored in a deep freezer
(−25∘C) until processing (maximum 10 hrs). The tissues were
homogenized in four volumes of ice-cold Tris-HCl buffer
(50mM, pH 7.4) using a glass Teflon homogenizer (Elektro-
crafts, Mumbai) for 2min at 5000 rpm after cutting it into
small pieces. The homogenate was then centrifuged (Remi,
India) at 1000 rpm for 10min to remove the debris. The clear
upper supernatant fluid was extracted with an equal volume
of ethanol and centrifuged at 17000 rpm for 30min; the clear
upper ethanol layer was taken and used for biochemical
assay. All the preparations were performed at 4∘C, and then
MDA, SOD, CAT, MAO, and AChE were estimated using
commercial kits according to the manufacturer’s protocols.
2.8.1. Determination of MDA Content in the Brain Tissue of
Mice. The method of detecting MDA was based on a stable
chromophoric product formed by reaction with thiobarbi-
turic acid (TBA), which could be measured at the wavelength
of 532 nm [12]. The calculation is MDA level (pmol/mg
prot) = (absorbance of test tube − absorbance of blank
tube)/(absorbance of standard tube−Absorbance of standard
blank tube) × 10 nmol/mL × dilution multiple/protein level
(mg prot/mL).
2.8.2. Determination of SOD Activity in the Brain Tissue
of Mice. The assay of total SOD was based on its ability
to inhibit the oxidation by the xanthine-oxidase xanthine
system [13]. The activities were quantified by measuring the
amount of hydroxylamine nitrite produced by the oxida-
tion of oxymin. The absorbance of the reaction product
was measured at 550 nm. The calculation is SOD activity
(U/mg prot) = (absorbance of control tube − absorbance
of test tube)/absorbance of control tube/50% × dilution
multiple/protein level (mg prot/mL).
2.8.3. Determination of Catalase Activity in the Brain Tissue
of Mice. The CAT activities were assessed by measuring the
disappearance of hydrogen peroxide at 405 nm [14, 15]. All
procedures complied with the manufacturer’s instructions.
One unit (U) of CAT corresponds to the amount of the
enzyme that hydrolyses 1mmol of hydrogen peroxide per
minute at 25∘C.The catalase activity was expressed as nmoles
of H
2
O
2
metabolized/mg protein/h.
2.8.4. Determination of MAO Activity in the Brain Tissue of
Mice. The activity of MAO was based on the production of
benzyl aldehyde from the reaction and its specific substrate,
aniline hydrochloride [16]. Briefly, the protein concentra-
tions were determined by the Lowry method using bovine
serum albumin as a standard. The homogenate was then
incubated (37∘C, 30min) in reaction buffer containing aniline
hydrochloride. The absorbance of the reaction product was
measured at 242 nm. One unit (U) of MAO activity was
defined as the amount that increased the absorbance by 0.01
at 37∘C. Therefore, MAO activity was expressed as U/mg
protein.
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2.8.5. Determination of AChE Activity in the Brain Tissue
of Mice. AChE activity was determined as described by
Ellman et al. [17] with some modifications. In brief, 30 𝜇L
of diluted homogenate was added to the reaction mixture,
which contained 100mM phosphate buffer (pH 8.0) and
1.0mM 5, 5󸀠-dithiobis-2-nitrobenzoic acid (DTNB) in 2mL,
and incubated at 37∘C for 6min. Hydrolysis was monitored
by the formation of the thiolate dianion of DTNB at 412 nm
for 2-3min with a spectrophotometer. AChE was calculated
from the quotient between lymphocyte AChE activity and
protein content. One unit (U) of enzyme activity was defined
as 1 micromole of ACh hydrolyzed per hour and per mg of
brain homogenate or per mL of blood (pH 8.0, 25∘C).
2.9. Data Analysis. All tests were analyzed using the Sta-
tistical Package SPSS 16.0 (SPSS Inc., Illinois, Chicago,
USA). Data were expressed as mean ± standard error of
mean (S.E.M) and analyzed by one-way analysis of variance
(ANOVA) followed by Dunnett’s 𝑡-test. A value of 𝑃 < 0.05
was considered statistically significant.
3. Results
3.1. Effect of EPT on Mouse Locomotive Activities in the Open-
Field. As shown in Figure 2, no significant effect of EPT
(50, 100, and 200mg/kg) on mouse locomotive activities was
observed in the open-field test. But galantamine 3mg/kg
reduced the total distance significantly compared with the
aged control group (𝑃 < 0.05).
3.2. Effect of EPT on the Aged Mice in Morris Water Maze Test
3.2.1. Acquisition Trials. As shown in Figures 3(a) and 3(b),
the escape latency deceased and the escape rate increased over
the course of training trials in all groups, which indicated that
learning and memory functions of mice improved with the
extension of training. Significant differences were observed
between the normal control group (3-month mice) and the
aged control group (15-month mice) at sessions 2 and 3 on
the escape latency and at sessions 1 and 2 on escape rate in
the training trials. The results indicated that 15-month mice
took a longer time to locate the platform than 3-month mice
did and 15-month mice had already undergone deterioration
of the spatial memory ability. No significant differences
appeared on the escape rate at session 3 when over 80% mice
could find the platform. However, EPT could notably shorten
the escape latency and raise the escape rate of the aged mice.
Significant differences were observed in the EPT (200 and
100mg/kg) treated groups as compared with the aged control
group (𝑃 < 0.05 or 𝑃 < 0.01). Similarly, the treatment
with galantamine (3mg/kg), a positive agent, showed little
influence on the escape latency and escape rate. However,
there were no significant differences on swimming speed in
the whole training trials among all the groups (Figure 3(c)).
3.2.2. Probe Trials. As shown in Figure 4(b), the crossing
numbers were significantly lower in the aged control mice
than those in the normal control mice (𝑃 < 0.01).
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Figure 2: Effect of EPT on locomotive activities of mice. Data
represent the mean ± S.E.M, 𝑛 = 8–10 in each group. Gal represents
galantamine 3mg/kg group. The total distance traveled by mice
was measured after repeated administrations of EPT (50, 100, and
200mg/kg) for 4 weeks. ∗𝑃 < 0.05 compared with the aged control
group.
By contrast, EPT (100 and 200mg/kg) and galantamine
(3mg/kg) increased the crossing numbers markedly (𝑃 <
0.05). Additionally, the shorter swimming time in the target
quadrant in the aged mice was significantly reversed by EPT
(100 and 200mg/kg). (Figure 4(a), 𝑃 < 0.05). A similar result
was also observed for the swimming distance in the target
quadrant (Figure 4(c), 𝑃 < 0.05). Meanwhile, the swimming
speed of all mice showed no differences in the probe trials
(Figure 4(d)).
3.2.3. Memory Retention Test. As shown in Figure 4(e), 15-
month mice had much longer escape latency than 3-month
mice in all the memory retention tests (𝑃 < 0.01 in session
1 and 𝑃 < 0.05 in sessions 2 and 3, resp.). By contrast,
the aged mice treated with different concentrations of EPT
obviously cut down the escape latency as compared with the
aged control mice. This indicated that EPT could promote
memory retention ability of the aged mice to certain extent,
and the significant differences were observed as shown in
Figure 4(e) (𝑃 < 0.05 or 𝑃 < 0.01).
3.3. Effect of EPT on the Aged Mice in Step-Down Task. In
the acquisition trials, the aged control mice revealed marked
differences for the latency (Figure 5(c)), the time spent in the
safe zone, and on the electric grid (Figures 5(b) and 5(a)) as
compared with the normal control mice (𝑃 < 0.05 or 𝑃 <
0.01). By contrast, EPT (100 and 200mg/kg) and galantamine
(3mg/kg) could shorten the latency and the time spent on the
electric grid and increase the time spent in the safety zone
significantly (𝑃 < 0.01 or 𝑃 < 0.05).
In the consolidation trials, the aged mice had longer time
on the electric grid than the normal control mice (𝑃 <
0.01). By contrast, EPT (100 and 200mg/kg) and galantamine
(3mg/kg) could decrease the time on the electric grid of the
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Figure 3: Effect of EPT on the acquisition phase inMWMtests of the agedmice. Training trials were carried out on day 2 to day 7 of behavioral
tests, (a) escape latency, (b) escape rate, and (c) swimming speed. Gal 3mg/kg represents galantamine 3mg/kg group. Values represent mean
± S.E.M (𝑛 = 8–10 in each group). #𝑃 < 0.05 compared with the normal group; ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 compared with the aged control
group.
agedmice obviously as comparedwith that of the aged control
mice (𝑃 < 0.01 or 𝑃 < 0.05) (Figure 5(e)). However, no
significant differences were observed in all groups on the time
in safety zone (Figure 5(d)).
In the retrial tests, the aged control mice still displayed
significant differences for the latency, the time spent in the
safety zone, and the time spent on the electric grid as com-
pared with the normal control mice. But by treatment with
EPT and galantamine, learning and memory performances
were manifestly improved, except low EPT group (50mg/kg)
(𝑃 < 0.01 or 𝑃 < 0.05) (Figures 5(f)–5(h)).
3.4. Effect of EPT onMDA Levels and CAT and SOD Activities
in the Brain Tissue of Mice. As shown in Figure 6(a), the
MDA levels in the aged control mice were higher than
those in the normal control mice (𝑃 < 0.01). Galantamine
(3mg/kg) and EPT (100 and 200mg/kg) decreased the MDA
levels significantly as compared with the aged control mice
(𝑃 < 0.05). EPT (50mg/kg) had the same tendency without
statistical difference. As can been seen in Figures 6(b) and
6(c), both CAT and SOD activities of brain tissue in the aged
control mice decreased significantly as compared with the
normal control mice (𝑃 < 0.05). However, mice treated with
EPT (200mg/kg) and galantamine (3mg/kg) showed high
CAT and SOD activities as compared with the aged control
mice (𝑃 < 0.05 or 𝑃 < 0.01). There was a slight increase of
both SOD and CAT activities in EPT (50, 100mg/kg) groups,
but no significant differences were observed compared with
the aged control group except the group of EPT (100mg/kg)
for SOD activity (𝑃 < 0.05).
3.5. Effect of EPT on MAO and AChE Activities in the Brain
Tissue of Mice. As could be seen in Figures 7(a) and 7(b),
the aged mice showed significant differences in MAO and
AChE activities as compared with the normal control mice
(𝑃 < 0.05). On the contrary, treated with EPT (100 and
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Figure 4: Effect of EPT on the probe and memory retention in MWM tests of the aged mice. The probe trial was performed 24 h after the
acquisition test, (a) swimming time in target quadrant, (b) crossing numbers, (c) swimming distance in target quadrant, (d) swimming speed,
and (e) escape latency on memory retention test. Gal 3mg/kg represents galantamine 3mg/kg group. Values represent mean ± S.E.M (𝑛 =
8–10 in each group). #𝑃 < 0.05 and ##𝑃 < 0.01 compared with the normal control group; ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 compared with the aged
control group.
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Figure 5: Effect of EPT on memory deficits of the aged mice in the step-down passive avoidance test. Figures 5(a)–5(c), 5(d) and 5(e), and
5(f)–5(h) represent the tests of acquisition, consolidation, and retrial, respectively. Figures 5(a), 5(e), and 5(f) show the time spent on electric
grid; Figures 5(c) and 5(h) show latency; and Figures 5(b), 5(d), and 5(g) show the time spent in safety zone. Values represent mean ± S.E.M
(𝑛 = 8–10 in each group). Gal 3mg/kg represents galantamine 3mg/kg group. #𝑃 < 0.05 and ##𝑃 < 0.01, versus the normal control group;
∗
𝑃 < 0.05 and ∗∗𝑃 < 0.01, versus the aged control group.
200mg/kg) and galantamine (3mg/kg), the activities ofMAO
and AChE could markedly decrease (𝑃 < 0.05 or 𝑃 < 0.01).
4. Discussion
Learning andmemory abilities are important functions of the
brain in humans and rodents. Aging in humans is associated
with deterioration of cognitive performance, particularly,
learning and memory abilities [18]. Aging animals have
traditionally been used as a model of memory impairments
[19]. Behavioral tests are one of the most reliable methods
to investigate learning and memory abilities of animals.
Generally, the animal’s behavioral changes are detected by
using Morris water maze and step-down and step-through
tests [20–22]. The extract of Polygala tenuifolia (EPT) has
been used as memory enhancer in Asia for thousands of
years. Various animal models have demonstrated that EPT
could improve brain functions [5–9]. In the present study, the
memory-enhancing effects of EPT on the normal aged mice
have been investigated by using Morris water maze and step-
down passive avoidance tests.
Morris watermaze is generally accepted as an indicator of
spatial learning and reference memory. In the present study,
spatial learning was assessed by repeated trials and evaluated
by escape latency and escape rate; reference memory was
determined by the preference of the platform area when
the platform was absent and recorded by crossing numbers,
swimming time, and swimming distance in the target quad-
rant; memory retention was measured by escape latency.
In acquisition phase, different indexes revealed different
sensitivities to evaluating learning and memory functions.
When using the escape latency as an index, the learning
and memory deterioration in aged control group appeared
obviously different from the normal control group in all 3
sessions, but it could be counteracted partly by EPT (100 and
200mg/kg) in session 2 and session 3 (Figure 3(a)). When
8 Evidence-Based Complementary and Alternative Medicine
##
∗
∗∗
Th
e c
on
te
nt
 o
f M
D
A
 (n
m
ol
/m
g 
pr
o)
0.20
0.15
0.10
0.05
0.00
Normal control
Aged control
Gal 3mg/kg
EPT 50mg/kg
EPT 100mg/kg
EPT 200mg/kg
(a)
#
∗
∗
120
90
60
30
0
CA
T 
ac
tiv
ity
 in
 b
ra
in
 (U
/m
g 
pr
o)
Normal control
Aged control
Gal 3mg/kg
EPT 50mg/kg
EPT 100mg/kg
EPT 200mg/kg
(b)
#
∗
∗
∗
∗
SO
D
 ac
tiv
ity
 in
 b
ra
in
 (U
/m
g 
pr
o)
8
6
4
2
0
Normal control
Aged control
Gal 3mg/kg
EPT 50mg/kg
EPT 100mg/kg
EPT 200mg/kg
(c)
Figure 6: Effect of EPT on the changes of MDA levels and CAT and SOD activities in mice brain tissue. (a) MDA levels, (b) CAT activity,
and (c) SOD activity. Values represent the mean ± S.E.M (𝑛 = 8–10 in each group). Gal represents galantamine 3mg/kg group. #𝑃 < 0.05 and
##
𝑃 < 0.01, versus the normal control group; ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01, versus the aged control group.
using the escape rate as an index, EPT showed strong improv-
ing effects in all 3 sessions, but there was almost no difference
among all groups in session 3 (Figure 3(b)). During the probe
trials, EPT (100 and 200mg/kg) significantly increased the
swimming time and distance in the target quadrant (Figures
4(a) and 4(c)). This effect was not due to a different motor
activity, for the mean swimming speed was not significantly
different among all groups (Figure 4(d)). Moreover, the aged
control group and EPT-treated groups showed comparable
locomotor activity and emotional reactivity in the open-field
test, which can also suggest that the amelioration of learning
andmemory in agedmice was not provoked by sensorimotor
effects. In memory retention test, treatment with different
concentrations of EPT on the aged mice obviously cut down
the escape latency as compared with the aged control mice
(Figure 4(e)).
Step-down passive avoidance task, which is a test of
fear motivated inhibitory avoidance indicating nonspatial
learning and memory [23], was performed to confirm the
effects of EPT on another type of learning andmemory ability
of the aged mice. The results demonstrated that EPT could
improve the memory impairment of the aged mice (Figure 5)
and further proved the therapeutic effects of EPT. Moreover,
latency, the time spent on the electric grid, and the time spent
on the safety zone presented mutual support in acquisition
and retrial trials. However, in consolidation trial, the time
spent in the safety zone showedno obvious differences among
all groups (Figure 5(d)), which might be related to the short-
term memory because the consolidation test was carried out
just 24 h after training trial. Taken together, EPT (100 and
200mg/kg) improved the memory performances of the aged
mice with multiple data in MWM and step-down tests.
It is well known that learning and memory deficits are
accompanied by aging. The exact mechanisms responsible
for the memory impairments with aging are still unclear,
but evidence has accumulated that oxidative stress plays an
Evidence-Based Complementary and Alternative Medicine 9
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Figure 7: Effect of EPT on the changes of MAO (a) and AChE (b) activities in mice. Each value represents the mean ± S.E.M (𝑛 = 8–10 in
each group). Gal represents galantamine 3mg/kg group. #𝑃 < 0.05, versus the normal control group; ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01, versus the
aged control group.
important role [24–26]. Oxidative stress occurs when pro-
oxidant and antioxidant levels become imbalanced. With
aging, there is an increased production of reactive oxy-
gen species (ROS) and diminished endogenous antioxidant
enzyme levels, leading to an increased oxidizing cellular
environment. Both SOD and CAT are the main endogenous
antioxidant enzymes, playing an important role in the intra-
cellular antioxidant defense in the brain. MDA, an important
lipid peroxidation product, can be taken as an indicator for
the state of oxidative damage of membranes under condition
of oxidative stress. Two antioxidant markers SOD and CAT
along with one oxidative stress marker MDA were measured
in the current study. The results showed that the increasing
MDA content and the decreasing activities of SOD and CAT
in the aged mice could be partly reversed by EPT (100,
200mg/kg) (Figure 6). These findings demonstrated that the
memory enhancing effects of EPT on the aged mice may be
via antioxidant system.
Aging is often accompanied by some alterations in
the neurotransmitter systems such as acetylcholine and
monoamine transmitters [27, 28]. And the transmission
of these neurotransmitters in the brain has been long
considered an important modulator of synaptic plasticity,
memory consolidation, and other cognitive processes [29,
30]. Under normal condition, the metabolic controls, which
are responsible for maintaining the levels of ACh and
monoamine transmitters, are catalyzed by AChE and MAO,
respectively [31, 32]. Our experimental data suggest that
the EPT-mediated enhancement in spatial and non-spatial
learning and memory abilities could be, at least partially,
due to the decreasing activity of AChE and MAO in aged
control mice (Figure 7), which were consistent with multiple
behavioral tendencies.
In summary, administration of EPT not only ameliorated
learning and memory deficits in the aged mice, but also
generated antioxidant effect via the endogenous enzymatic
system. Our results supported the fact that EPT possesses
memory-enhancing effects in healthy [33] and elderly vol-
unteers [34]. Although the mechanisms for the memory
enhancing effects of EPT are still unclear, evidence is asso-
ciated with complicated changes of neural network system
and antiaging effects. Potential mechanismswhichmake EPT
an effective agent for treating learning and memory disor-
ders might be partially related to improved antioxidation
and reduced activities of AChE and MAO. By combining
analytical chemistry and chemogenomics [35] in the future,
we aim to identify the memory-enhancing phytochemicals
within EPT and elucidate their molecular mechanisms.
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